GSA Capital Partners’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-46,782
| Closed | -$245K | – | 1976 |
|
2023
Q3 | $245K | Sell |
46,782
-152,034
| -76% | -$796K | 0.02% | 1193 |
|
2023
Q2 | $372K | Buy |
198,816
+156,309
| +368% | +$292K | 0.04% | 921 |
|
2023
Q1 | $159K | Sell |
42,507
-127,338
| -75% | -$476K | 0.02% | 1298 |
|
2022
Q4 | $525K | Sell |
169,845
-4,231
| -2% | -$13.1K | 0.07% | 570 |
|
2022
Q3 | $794K | Buy |
174,076
+169,478
| +3,686% | +$773K | 0.11% | 265 |
|
2022
Q2 | $121K | Buy |
4,598
+2,132
| +86% | +$56.1K | 0.02% | 1190 |
|
2022
Q1 | $92K | Buy |
+2,466
| New | +$92K | 0.01% | 1303 |
|
2021
Q4 | – | Sell |
-1,066
| Closed | -$88K | – | 1835 |
|
2021
Q3 | $88K | Buy |
+1,066
| New | +$88K | 0.01% | 1333 |
|